Recent Finacing
Recent Raise
EG 427, a Paris-based biotech developing a non-replicating HSV‑1 HERMES vector to deliver durable transgenes; lead EG110A delivers botulinum F light chain to silence C-fiber sensory neurons for neurogenic bladder
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
